70-Year-old woman with rash and muscle weakness

Mayo Clinic Proceedings

Volumn 79, Issue 7, 2004, Pages 923-926

  Mehta, Vinay ^a   Swaroop, Vege Santhi ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER SCREENING; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROMYOGRAM; FEMALE; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; MUSCLE WEAKNESS; RASH; STOMACH CARCINOMA;

EID: 3042817149     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.7.923     Document Type: Article

References (12)

1. Fafalak RG, Peterson MG, Kagen LJ. Strength in polymyositis and dermatomyositis: best outcome in patients treated early. J Rheumatol. 1994; 21:643-648.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-347.
3. Barnes BE, Mawr B. Dermatomyositis and malignancy: a review of the literature. Ann Intern Med. 1976;84:68-76.
4. Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ III. Polymyositis- dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc. 1986;61:645-653.
5. Manchul LA, Jin A, Pritchard KI, et al. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis: a controlled study. Arch Intern Med. 1985;145:1835-1839.
6. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med. 1992;326:363-367.
7. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population-based cohort study. Ann Intern Med. 2001;134:1087-1095.
8. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96-100.
9. Callen JP. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? [editorial]. Arch Dermatol. 2002;138:969-971.
10. Sparsa A, Liozon E, Herrmann F, et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol. 2002;138:885-890.
11. Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF Jr. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 1995;6:9-13.
12. Provost TT, Flynn JA. Dermatomyositis. In: Provost TT, Flynn JA, eds. Cutaneous Medicine: Cutaneous Manifestations of Systemic Disease. Hamilton, Ontario: BC Decker Inc; 2001:82-103.